Had a great return on those shares and am now re-entering.
Biotech may still be under pressure for a bit longer, but I love this company's technology and potential to make a huge difference in the lives of those with SCI.
Incidentally, we had several huge winners this hear besides NVIV- and subscription is free:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.